AI Summary
StalkAlthough NOMD remains in a Stage 2 advance marked by higher highs and lows and rising short-term EMAs, the active Bullish Exhaustion pattern and extreme overbought readings suggest upside momentum is waning. Price is extended well above the 9 and 20 EMAs and RSI is flattening at the upper band, so pullbacks into these EMAs would offer more favorable entry points. The medium-term bias stays bullish under the advancing regime, while the long-term trend remains negative below the 200 DMA. In line with a defensive Free Cash Flow + Buybacks strategy, execution is deferred pending a corrective pullback to enhance asymmetric risk–reward.
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | Buy | NOMD | Dominic Brisby | Chief Executive Officer | 150,000 | $9.79 | $1.6B | -37.21% | +28.03% | $1.5M | +2.57% | — | Buy Now |
| May 14, 2026 | Buy | NOMD | Ruben Baldew | Chief Financial Officer | 14,731 | $9.71 | $1.6B | -37.21% | +28.03% | $143.1K | +0.62% | — | Buy Now |